Keyword Analysis & Research: capecitabine package insert

fda.gov

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020896s037lbl.pdf

File Size: 798KB Page Count: 46

File Size: 798KB

Page Count: 46

DA: 74 PA: 1 MOZ Rank: 83

fda.gov

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020896s026lbl.pdf

WEBXELODA is a nucleoside metabolic inhibitor with antineoplastic activity for adjuvant and metastatic colon and breast cancers. See dosage, warnings, precautions, … File Size: 544KB Page Count: 38

File Size: 544KB

Page Count: 38

DA: 2 PA: 38 MOZ Rank: 16

drugs.com

https://www.drugs.com/pro/xeloda.html

OverviewHighlights of Prescribing InformationSee full prescribing information for complete boxed warning.Indications and Usage for XelodaXeloda Dosage and AdministrationContraindicationsWarnings and PrecautionsAdverse Reactions/Side Effects XELODA (capecitabine) is a nucleoside metabolic inhibitor indicated for: Colorectal Cancer •adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component …•perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy. (1.1) Published: Apr 30, 1998

XELODA (capecitabine) is a nucleoside metabolic inhibitor indicated for: Colorectal Cancer

•adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component …•perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy. (1.1)

Published: Apr 30, 1998

DA: 26 PA: 91 MOZ Rank: 63

roche.com

https://assets.roche.com/f/176330/x/62637d78ab/xeloda-pi-v12-0-dt-dec-2021.pdf

WEBXeloda is a cytostatic agent for the treatment of breast, colorectal and gastric cancer. The label provides information on dosage, administration, warnings, precautions and clinical …

DA: 60 PA: 61 MOZ Rank: 21

roche.com

https://assets.cwp.roche.com/f/170883/x/47b1e3c823/xeloda-pi-dec-2020.pdf

WEBXeloda® Capecitabine Patients taking Xeloda should be informed of the need to interrupt treatment immediately if moderate or severe toxicity occurs. Doses of Xeloda omitted for …

DA: 86 PA: 70 MOZ Rank: 25

microsoft.com

https://go.microsoft.com/fwlink/?linkid=2100071&clcid=0x409

Common brand names: XelodaOVERVIEWSIDE EFFECTSINTERACTIONSDOSAGEInteractionsInteractionsProduct interactions for this drug/drug-class include:Fluorouracil & Fluorouracil Prodrugs with Brivudine (Contraindicated)Nadofaragene Firadenovec with Selected Immunosuppressants (Contraindicated)Talimogene laherparepvec with Selected Immunosuppressants (Contraindicated)Live Vaccines; Live BCG with Selected Immunosuppressive Agents (Contraindicated)Efalizumab; Natalizumab with Immunosuppressives; Immunomodulators (Contraindicated)Fluorouracil with Metronidazole; Tinidazole (Severe Interaction) Fluorouracil & Fluorouracil Prodrugs with Brivudine (Contraindicated) Nadofaragene Firadenovec with Selected Immunosuppressants (Contraindicated) Talimogene laherparepvec with Selected Immunosuppressants (Contraindicated) Live Vaccines; Live BCG with Selected Immunosuppressive Agents (Contraindicated) Efalizumab; Natalizumab with Immunosuppressives; Immunomodulators (Contraindicated) Fluorouracil with Metronidazole; Tinidazole (Severe Interaction) Lack of a certain enzyme (dihydropyrimidine dehydrogenase - DPD) Blood disorders (such as bone marrow suppression) Heart problems (such as heart failure) Kidney disease Liver problems Warning: Do not use if you are pregnant, suspect that you are pregnant, or while breastfeeding. Consult your doctor or pharmacist. ; Take this medication after a meal. Read label carefully for how many times to take each day. ; Swallow whole. Do not chew or crush. ; May cause dizziness ; Pregnant women should avoid contact with this medication. ; CAUTION. Follow procedures for proper handling and disposal of hazardous drugs. ; This drug may impair the ability to operate a vehicle, vessel (e.g., boat), or machinery. Use care until you become familiar with its effects. ;

Fluorouracil & Fluorouracil Prodrugs with Brivudine (Contraindicated)

Nadofaragene Firadenovec with Selected Immunosuppressants (Contraindicated)

Talimogene laherparepvec with Selected Immunosuppressants (Contraindicated)

Live Vaccines; Live BCG with Selected Immunosuppressive Agents (Contraindicated)

Efalizumab; Natalizumab with Immunosuppressives; Immunomodulators (Contraindicated)

Fluorouracil with Metronidazole; Tinidazole (Severe Interaction)

Lack of a certain enzyme (dihydropyrimidine dehydrogenase - DPD)

Blood disorders (such as bone marrow suppression)

Heart problems (such as heart failure)

Kidney disease

Liver problems

Warning: Do not use if you are pregnant, suspect that you are pregnant, or while breastfeeding. Consult your doctor or pharmacist. ; Take this medication after a meal. Read label carefully for how many times to take each day. ; Swallow whole. Do not chew or crush. ; May cause dizziness ; Pregnant women should avoid contact with this medication. ; CAUTION. Follow procedures for proper handling and disposal of hazardous drugs. ; This drug may impair the ability to operate a vehicle, vessel (e.g., boat), or machinery. Use care until you become familiar with its effects. ;

DA: 6 PA: 31 MOZ Rank: 2

fda.gov

https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020896s016lbl.pdf

DA: 80 PA: 80 MOZ Rank: 27

gene.com

https://www.gene.com/download/pdf/xeloda_ppi.pdf

WEBXELODA is a prescription medicine used to treat certain types of cancer. Learn about its side effects, interactions, dosage, and precautions before taking it.

DA: 58 PA: 17 MOZ Rank: 34

roche.com

https://assets.roche.com/f/173850/x/9134445890/xeloda_pm_e.pdf

WEBbeen observed with XELODA (see Cardiovascular below). • XELODA can induce severe skin reactions such as hand-and-foot syndrome, Stevens-Johnson syndrome and Toxic …

DA: 79 PA: 8 MOZ Rank: 78